Venus MedTech agrees private placement of 184,536,703 shares at HKD 1.08 each

• Venus Medtech signed a subscription agreement on Sept. 10, 2026 for 184,536,703 new shares at HKD 1.08.
• Share sale size: HKD 198.93 million, or RMB 171.91 million if issued as Domestic Shares.
• Deal also includes new Convertible Bonds with principal up to HKD 379.65 million, convertible at HKD 1.19.
• Combined investment amount up to RMB 500 million, aimed at shoring up liquidity amid losses in the six months ended June 30, 2026.
• Issuance requires shareholder approval at an EGM, with shares issued under a specific mandate.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Venus MedTech HangZhou Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260910-12328408), on September 10, 2026, and is solely responsible for the information contained therein.